Celmatix

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Celmatix is a data-driven, research-stage precision health company leveraging insights from its proprietary multi-omic discovery platform, Reproductive Atlas, to develop transformational therapeutics in previously under-studied areas of women’s health. With a lead program in ovarian senescence and additional programs in non-hormonal contraceptives and specialty indications such as endometriosis and polycystic ovary syndrome (PCOS), Celmatix is developing the next generation of interventions in its field and supporting its partners in bringing innovation to a high-value market with large unmet need.
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2009
Main Therapeutic Focus:
Lead Product in Development:
Ovarian Senescence
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
CEO
Celmatix